Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2010

View Archived Issues

Clinical data show improved antihypertensive efficacy of intensive amlodipine/valsartan/HCTZ

Novel stearoyl-CoA desaturase inhibitors disclosed by Gilead

GlaxoSmithKline claims novel antibacterial agents

Novel PKB alpha/Akt1 inhibitors discovered at GlaxoSmithKline

DNA Medicine Institute receives grant for noninvasive malaria test

Galapagos and Roche expand COPD therapy alliance

Harbor Biosciences reports results of phase IIa Triolex trial in diabetes

Envivo initiates phase IIb EVP-6124 trial in Alzheimer's disease

Quest PharmaTech doses first patient in prostate cancer trial

MAP Pharmaceuticals provides update on Levadex development program

Promising preclinical effect of pan PI3Kalpha inhibitor NVP-BKM-120 disclosed

Eotaxin serum levels, retinal expression increased in age-related macular degeneration

FLT3/ITD kinase inhibitors ITRI-260 and ITRI-376 potential candidates for AML treatment

Seasonal flu vaccine VAX-125 immunogenic in elderly subjects

BioChromix discovers novel thiophene derivatives

Phase III data on AIDSVAX gp120 B/E and ALVAC vCP1521 show protective effect

IntelGenx acquires full ownership of CPI-300 from Cary

Lundbeck discovers novel tachykinin NK3 antagonists

GSK and Response Genetics enter license agreement for BRAF gene mutation testing

FDA advisory committee review of Luveniq NDA set for June

Abbott licenses Zydus Cadila products for fast-growing emerging markets

First quarter developments at Merck & Co.

Eisai receives Japanese approval of Tambocor for tachyarrhythmia in children

Schering-Plough launches Temodal injection in Japan

GSK and FDA report important safety finding from Promacta study in chronic liver disease

Cell Therapeutics and NCCTG to conduct phase II study of pixantrone in metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...